Therefore, it is of interest to assess p53, Ki-67 and EGFR expression via immunohistochemistry in 96 confirmed OSCC cases, correlating with grade, lymph node metastasis and stage. The gene discussed is TP53; the disease is metastatic malignant neoplasm in the lymph nodes.